A Single Ascending Dose, and Food Effect Study of ABBV-7828 in Healthy Adults
Part of paid clinical trials in Grayslake, Illinois.
- Sponsor
- AbbVie
- Study ID
- NCT07856706
- Phase
- PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Healthy Subjects
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- ABBV-7828 — DRUGOral administration
- Placebo for ABBV-7828 — DRUGOral administration
Study Details
This study is to evaluate safety, tolerability, pharmacokinetics and effect of food on ABBV-7828 compared to placebo in healthy adult participants.
Key Dates
- First listed
- Oct 5, 2026
- Start date
- Sep 21, 2026
- Status verified
- Sep 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Part 1: ABBV-7828Participants will receive single doses of ABBV-7828.
- Placebo Comparator: Part 1: PlaceboParticipants will receive single doses of placebo.
- Experimental: Part 2: ABBV-7828 Sequence 1Participants will receive ABBV-7828 while in fasting in Period 1 followed by ABBV-7828 after high fat/high calorie meal in Period 2.
- Experimental: Part 2: ABBV-7828 Sequence 2Participants will receive ABBV-7828 after a high-fat/high calorie meal in Period 1 followed by ABBV-7828 in fasting conditions in Period 2.
Primary Outcome Measure
Number of Participants with Adverse Events (AEs) [ Time Frame: Up to approximately 38 days ]
Central Contacts
- ABBVIE CALL CENTER844-663-3742
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Acpru /Id# 283545 | Grayslake | Illinois | 60030 | - |
Find similar trials in Grayslake, IL
By research site
Related Studies
- Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)Recruiting · National Institute of Dental and Craniofacial Research (NIDCR) · Bethesda, Maryland
- Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)Recruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Optimizing Ultrasound-induced Anti-inflammation in Human SubjectsRecruiting · University of Virginia · Charlottesville, Virginia
- Single-tracer Multiparametric PET ImagingEARLY_PHASE1 · Recruiting · University of California, Davis · Sacramento, California